JP2023544842A5 - - Google Patents
Info
- Publication number
- JP2023544842A5 JP2023544842A5 JP2023521558A JP2023521558A JP2023544842A5 JP 2023544842 A5 JP2023544842 A5 JP 2023544842A5 JP 2023521558 A JP2023521558 A JP 2023521558A JP 2023521558 A JP2023521558 A JP 2023521558A JP 2023544842 A5 JP2023544842 A5 JP 2023544842A5
- Authority
- JP
- Japan
- Prior art keywords
- peptoid
- pharmaceutical composition
- independently
- formula
- ch2ch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2010186A FR3114739B1 (fr) | 2020-10-06 | 2020-10-06 | Nouveaux peptoides et leur utilisation dans la prevention ou le traitement de la douleur chronique |
| FR2010186 | 2020-10-06 | ||
| PCT/FR2021/051694 WO2022074313A1 (fr) | 2020-10-06 | 2021-09-30 | Nouveaux peptoides et leur utilisation dans la prevention ou le traitement de la douleur chronique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544842A JP2023544842A (ja) | 2023-10-25 |
| JP2023544842A5 true JP2023544842A5 (enExample) | 2024-10-02 |
| JP7853288B2 JP7853288B2 (ja) | 2026-04-28 |
Family
ID=74553909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521558A Active JP7853288B2 (ja) | 2020-10-06 | 2021-09-30 | 新規ペプトイド及び慢性疼痛の予防又は治療におけるそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230374067A1 (enExample) |
| EP (1) | EP4225295B1 (enExample) |
| JP (1) | JP7853288B2 (enExample) |
| CN (1) | CN116744957A (enExample) |
| CA (1) | CA3194875A1 (enExample) |
| ES (1) | ES3005857T3 (enExample) |
| FR (1) | FR3114739B1 (enExample) |
| WO (1) | WO2022074313A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60100055T2 (de) * | 2001-03-21 | 2003-07-24 | Schwarz Pharma Ag | Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen |
| KR20080038408A (ko) * | 2005-08-18 | 2008-05-06 | 쉬바르츠파르마에이지 | 근육통 치료를 위한 펩티드 화합물의 신규한 용도 |
| EP2289886A1 (en) * | 2009-08-31 | 2011-03-02 | Institut d'Investigacions Biomédiques August PI I Sunyer | Peptoid agonists of nerve growth factor and their use as medicaments |
| US9216210B2 (en) * | 2013-12-23 | 2015-12-22 | Dublin City University | Multiprotease therapeutics for chronic pain |
| JP7120927B2 (ja) * | 2016-06-07 | 2022-08-17 | 江蘇恒瑞医薬股▲ふん▼有限公司 | フェニルプロパンアミド誘導体ならびにそれらの製造方法および医薬用途 |
| US11753432B2 (en) * | 2017-01-27 | 2023-09-12 | Academia Sinica | Compound with analgesic effect for use in prevention and treatment of pain |
-
2020
- 2020-10-06 FR FR2010186A patent/FR3114739B1/fr active Active
-
2021
- 2021-09-30 WO PCT/FR2021/051694 patent/WO2022074313A1/fr not_active Ceased
- 2021-09-30 CN CN202180068718.2A patent/CN116744957A/zh active Pending
- 2021-09-30 CA CA3194875A patent/CA3194875A1/fr active Pending
- 2021-09-30 US US18/248,240 patent/US20230374067A1/en active Pending
- 2021-09-30 JP JP2023521558A patent/JP7853288B2/ja active Active
- 2021-09-30 ES ES21798748T patent/ES3005857T3/es active Active
- 2021-09-30 EP EP21798748.6A patent/EP4225295B1/fr active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005533766A5 (enExample) | ||
| ES2572811T3 (es) | Mezclas de polipéptidos, composiciones que las contienen y procedimientos para obtener los mismos, y usos de los mismos | |
| RU97100789A (ru) | Новые производные замещенного пуринила, обладающие иммуномодуляторной активностью | |
| RU2007101039A (ru) | Иммуностимулирующие олигонуклеотидные мультимеры | |
| JP2017521496A5 (enExample) | ||
| JP2009500424A5 (enExample) | ||
| JP2024513391A5 (enExample) | ||
| JP2008543847A5 (enExample) | ||
| JP2013509389A5 (enExample) | ||
| CN109952304A (zh) | 一类抑制并降解cdk的化合物 | |
| JP2004509845A5 (enExample) | ||
| WO2012067138A1 (ja) | 新規なシチジン系代謝拮抗剤の高分子誘導体 | |
| JP2024545787A5 (enExample) | ||
| JP2004536046A5 (enExample) | ||
| JP2004521123A5 (enExample) | ||
| JP2006502117A5 (enExample) | ||
| RU2002123641A (ru) | С-4 карбонатсодержащие таксаны | |
| CA2451241A1 (en) | Unsymmetrical cyclic diamine compound | |
| CN103889409A (zh) | N-羟基-4-{2-[3-(n,n-二甲基氨基甲基)苯并呋喃-2-基羰基氨基]乙氧基}苯甲酰胺的给药方案 | |
| KR20130062953A (ko) | 안티센스 올리고뉴클레오티드를 포함하는 약학 조성물 및 이의 사용 방법 | |
| RU2011121354A (ru) | Синтетические миметики иммунной защиты и их применение | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2024073470A5 (enExample) | ||
| CA2738070A1 (en) | Novel compounds for the treatment or alleviation of edema, and methods for their use | |
| RU2008107871A (ru) | Применение ингибиторов hdac для лечения миеломы |